SignalXSignalX

HAE HAEMONETICS CORP

Q4 2025 10-Q
Filed: Feb 5, 2026Period ending Dec 27, 2025
Health Care
Surgical & Medical Instruments & ApparatusSEC EDGAR
HAEMONETICS CORP Overview

HAEMONETICS CORP (HAE) 10-Q quarterly report for Q4 2025, filed with SEC EDGAR on Feb 5, 2026 for the fiscal period ending Dec 27, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q4 2025 10-Q

Risk Factors

  • • Newly added geopolitical risk: heightened tensions in China, Taiwan, Russia, Ukraine, and the Middle East affecting operations
  • • Most materially updated operational risk: supply chain disruptions due to climate change, labor strikes, terrorism, and cyber incidents
+3 more insights

Get deeper insights on HAEMONETICS CORP

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.